Qing Xu

FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease

Emily Y. Jen, Qing Xu, Aaron J. Schetter et al. · Clinical Cancer Research · 2018 · 130 citations

Medicine, Hematology, Oncology +15

FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a <i>FLT3</i> Mutation

Dianne Pulte, Kelly J. Norsworthy, Yaping Wang et al. · Clinical Cancer Research · 2021 · 81 citations · Full text

Medicine, Hematology, Pharmacology +14

Adjunctive treatment with high frequency repetitive transcranial magnetic stimulation for the behavioral and psychological symptoms of patients with Alzheimer's disease: a randomized, double-blind, sham-controlled study.

Yue Wu, Wenwei Xu, Qing Xu et al. · PubMed · 2015 · 58 citations · Full text

Medicine, Neuroscience, Psychiatry +17

FDA Approval Summary: Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma

Andrea Baines, Rachel Ershler, Bindu Kanapuru et al. · Clinical Cancer Research · 2022 · 55 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Pseudo-partial likelihood estimators for the Cox regression model with missing covariates

Xiaodong Luo, Wei Yann Tsai, Qing Xu · Biometrika · 2009 · 25 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16